HF
STXS icon

HRT Financial’s Stereotaxis STXS Stock Holding History

HRT Financial’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,329
Closed -$42K – 4686
2025
Q4 		$42K Buy
+18,329
New +$48.8K ﹤0.01% 2899
2024
Q2 		– Sell
-111,090
Closed -$289K – 3065
2024
Q1 		$289K Buy
+111,090
New +$264K ﹤0.01% 1574
2023
Q2 		– Sell
-12,012
Closed -$24K – 3253
2023
Q1 		$24K Buy
+12,012
New +$27K ﹤0.01% 2171
2022
Q1 		– Sell
-56,551
Closed -$350K – 3829
2021
Q4 		$350K Buy
56,551
+37,237
+193% +$223K ﹤0.01% 2157
2021
Q3 		$103K Buy
+19,314
New +$146K ﹤0.01% 2892

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's STXS Position: Q1 2026 in Review

HRT Financial sold out of Stereotaxis (STXS) in Q1 2026, closing a stake of 18,329 shares — an estimated $42K sold.

HRT Financial first reported a position in STXS in Q3 2021 and held it in 5 quarters. The position peaked at $350K in Q4 2021. 115 funds tracked by Wall St. Rank hold STXS as of Q1 2026.

  • HRT Financial reported no remaining Stereotaxis position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 18,329 Stereotaxis shares in Q1 2026, an estimated $42K.
  • HRT Financial first reported a position in Stereotaxis in Q3 2021 and held it in 5 quarters.
  • HRT Financial's Stereotaxis position peaked at $350K in Q4 2021.
  • 115 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.